Ghys P D, Bélec L, Diallo M O, Ettiègne-Traoré V, Becquart P, Maurice C, Nkengasong J N, Coulibaly I M, Greenberg A E, Laga M, Wiktor S Z
Projet RETRO-CI, Abidjan, Côte d'Ivoire.
AIDS. 2000 Nov 10;14(16):2603-8. doi: 10.1097/00002030-200011100-00025.
To detect anti-HIV antibodies in cervicovaginal secretions of HIV-seronegative female sex workers and to evaluate whether the presence of these antibodies is associated with increased sexual exposure.
A cross-sectional study was carried out at a confidential clinic for female sex workers in Abidjan, Côte d'Ivoire. The participants were 342 HIV-seronegative female sex workers in whom a cervicovaginal lavage was collected. The main outcome measures were the detection of antibodies to HIV-1 in cervicovaginal lavages using an in-house and a commercial (Seradyn Sentinel; Calypte Biomedical Corporation, Berkeley, California, USA) enzyme immunoassay; the detection of semen in cervicovaginal lavages; and the assessment of epidemiological and biological markers of sexual exposure to HIV.
Cervicovaginal anti-HIV antibodies were detected in 7.3 and 29.8% of women using in-house enzyme-linked immunosorbent assay (ELISA) and Seradyn Sentinel respectively. All cervicovaginal secretions found to be positive by in-house ELISA were also positive by Seradyn Sentinel. In a minority of women, ranging from 2.9% by in-house ELISA to 12.3% by Seradyn Sentinel, the anti-HIV antibodies were present in vaginal fluids that did not contain semen. Sexual exposure to HIV was similar in women with anti-HIV antibodies in their semen-free cervicovaginal secretions compared with women without anti-HIV antibodies in their cervicovaginal secretions.
Cervicovaginal HIV-specific antibodies were detected in a minority of sexually exposed HIV-seronegative female sex workers in Abidjan. The lack of association between increased sexual exposure to HIV and presence of cervicovaginal HIV-specific antibodies suggests that the production of genital HIV-specific antibodies in exposed seronegative women depends on the ability of individual women to mount specific mucosal immunity to HIV antigens, the determinants of which are currently unknown.
检测HIV血清阴性的女性性工作者宫颈阴道分泌物中的抗HIV抗体,并评估这些抗体的存在是否与性暴露增加有关。
在科特迪瓦阿比让一家为女性性工作者开设的保密诊所开展了一项横断面研究。研究对象为342名HIV血清阴性的女性性工作者,收集了她们的宫颈阴道灌洗液。主要观察指标包括使用内部方法和一种商用酶免疫测定法(Seradyn Sentinel;Calypte Biomedical Corporation,美国加利福尼亚州伯克利)检测宫颈阴道灌洗液中的HIV-1抗体;检测宫颈阴道灌洗液中的精液;以及评估HIV性暴露的流行病学和生物学标志物。
分别使用内部酶联免疫吸附测定法(ELISA)和Seradyn Sentinel检测,发现7.3%和29.8%的女性宫颈阴道存在抗HIV抗体。所有经内部ELISA检测呈阳性的宫颈阴道分泌物经Seradyn Sentinel检测也呈阳性。在少数女性中,内部ELISA检测阳性率为2.9%,Seradyn Sentinel检测阳性率为12.3%,其不含精液的阴道分泌物中存在抗HIV抗体。精液阴性的宫颈阴道分泌物中存在抗HIV抗体的女性与宫颈阴道分泌物中无抗HIV抗体的女性相比,其HIV性暴露情况相似。
在阿比让少数有性暴露的HIV血清阴性女性性工作者中检测到了宫颈阴道HIV特异性抗体。HIV性暴露增加与宫颈阴道HIV特异性抗体的存在之间缺乏关联,这表明暴露的血清阴性女性中生殖器HIV特异性抗体的产生取决于个体女性对HIV抗原产生特异性黏膜免疫的能力,而其决定因素目前尚不清楚。